Corista: DP3’s momentum as a world-class integrated pathology solution grows Concord, MA (Feb. 7, 2024) – Corista, a leader in digital pathology solutions, is excited to announce that it has received a Class II Medical Device License...

From the Corista blog: The ICC Profile: What Is It and Why Is It Important When Considering Digital Pathology Technologies? Consistency and reliability of image quality is more important than ever as the adoption of digital pathology...

Evident, a wholly-owned subsidiary of Olympus Corporation is partnering with Corista to deliver digital pathology capabilities to clients worldwide CONCORD, MASS. (AUGUST 11, 2022) – Corista announces the collaboration with Evident, a...

Corista: Digital Solutions for Training Today's Pathologists The strains of the last two plus years have forced us to make many changes to our daily routines, both on a personal and a professional level. Remote interactions have become the...

Corista Expands Digital Pathology Functionality to Research and Education Applications Two new modules offer advancements for project- and course-based uses of DP3 Concord, MA (March 17, 2022) – As an innovator in digital pathology,...

 DP3’s latest update adds new tools, providing even more flexibility and power to your digital pathology applications. Concord, MA – Integrated pathology solutions leader, Corista, has released their latest version of DP3. DP3's...